Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial
Journal of the American Academy of Dermatology | Jan 19, 2018
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
Journal of the American Academy of Dermatology | Jan 19, 2018
Prevalence and outcomes of primary immunodeficiency in hospitalized children in the United States
The Journal of Allergy and Clinical Immunology: In Practice | Jan 18, 2018
The basophil activation test can be of value for diagnosing immediate allergic reactions to omeprazole
The Journal of Allergy and Clinical Immunology: In Practice | Jan 18, 2018
Anxiety and depression effects during drug provocation test
The Journal of Allergy and Clinical Immunology: In Practice | Jan 18, 2018
Mutations in PI3K110δ cause impaired NK cell function partially rescued by rapamycin treatment
The Journal of Allergy and Clinical Immunology | Jan 18, 2018
Anti-TNFα treatment in children and adolescents with combined inflammatory bowel disease and autoimmune liver disease
Journal of Pediatric Gastroenterology and Nutrition | Jan 18, 2018